BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9178688)

  • 1. Oxyntomodulin stimulates intestinal glucose uptake in rats.
    Collie NL; Zhu Z; Jordan S; Reeve JR
    Gastroenterology; 1997 Jun; 112(6):1961-70. PubMed ID: 9178688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
    Bataille D; Gespach C; Tatemoto K; Marie JC; Coudray AM; Rosselin G; Mutt V
    Peptides; 1981; 2 Suppl 2():41-4. PubMed ID: 6283496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and sequence of rat oxyntomodulin.
    Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pure enteroglucagon, oxyntomodulin (glucagon 37), stimulates insulin release in perfused rat pancreas.
    Jarrousse C; Bataille D; Jeanrenaud B
    Endocrinology; 1984 Jul; 115(1):102-5. PubMed ID: 6376068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
    Sigalet DL; Bawazir O; Martin GR; Wallace LE; Zaharko G; Miller A; Zubaidi A
    Dig Dis Sci; 2006 Sep; 51(9):1557-66. PubMed ID: 16927140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxyntomodulin inhibits food intake in the rat.
    Dakin CL; Gunn I; Small CJ; Edwards CM; Hay DL; Smith DM; Ghatei MA; Bloom SR
    Endocrinology; 2001 Oct; 142(10):4244-50. PubMed ID: 11564680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide.
    Bataille D; Coudray AM; Carlqvist M; Rosselin G; Mutt V
    FEBS Lett; 1982 Sep; 146(1):73-8. PubMed ID: 7140976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
    Kervran A; Blache P; Bataille D
    Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
    Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
    Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre.
    Thulesen J; Hartmann B; Nielsen C; Holst JJ; Poulsen SS
    Gut; 1999 Nov; 45(5):672-8. PubMed ID: 10517902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
    Dubrasquet M; Bataille D; Gespach C
    Biosci Rep; 1982 Jun; 2(6):391-5. PubMed ID: 6125221
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat.
    Biedzinski TM; Bataille D; Devaux MA; Sarles H
    Peptides; 1987; 8(6):967-72. PubMed ID: 3441447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Enterolglucagon': a specific effect on gastric glands isolated from the rat fundus. Evidence for an "oxyntomodulin' action.
    Bataille D; Gespach C; Coudray AM; Rosselin G
    Biosci Rep; 1981 Feb; 1(2):151-5. PubMed ID: 6271273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new role for enteric glucagon-37: acute stimulation of glucose absorption in rat small intestine.
    Stümpel F; Scholtka B; Jungermann K
    FEBS Lett; 1997 Jun; 410(2-3):515-9. PubMed ID: 9237694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioactive "enteroglucagon" (oxyntomodulin): evidence for a C-terminal extension of the glucagon molecule].
    Bataille D; Tatemoto K; Coudray AM; Rosselin G; Mutt V
    C R Seances Acad Sci III; 1981 Oct; 293(6):323-8. PubMed ID: 6797684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
    Baggio LL; Huang Q; Brown TJ; Drucker DJ
    Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.
    Schjoldager BT; Baldissera FG; Mortensen PE; Holst JJ; Christiansen J
    Eur J Clin Invest; 1988 Oct; 18(5):499-503. PubMed ID: 3147901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological significance of "enteroglucagon." Present status.
    Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
    Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
    Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.